HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Perioperative management of haemophilia A using recombinant factor VIII Fc fusion protein in a patient undergoing endoscopic nasal pituitary adenomectomy for a growth hormone-producing pituitary adenoma.

AuthorsA Okamoto, K Yamamoto, G Eguchi, T Yamaguchi, N Nishi, T Yamada, E Chen, Y Maeda
JournalHaemophilia : the official journal of the World Federation of Hemophilia (Haemophilia) Vol. 23 Issue 6 Pg. e525-e527 (11 2017) ISSN: 1365-2516 [Electronic] England
PMID28906056 (Publication Type: Letter)
Chemical References
  • Immunoglobulin Fc Fragments
  • Recombinant Fusion Proteins
  • factor VIII-Fc fusion protein
  • Human Growth Hormone
  • Factor VIII
Topics
  • Adult
  • Factor VIII (therapeutic use)
  • Hemophilia A (complications, drug therapy)
  • Human Growth Hormone (metabolism)
  • Humans
  • Immunoglobulin Fc Fragments (therapeutic use)
  • Male
  • Perioperative Period
  • Pituitary Gland (surgery)
  • Pituitary Neoplasms (complications, metabolism, surgery)
  • Recombinant Fusion Proteins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: